Dose of nafamostat mesylate during continuous kidney replacement therapy in critically ill patients: a two-centre observational study by Shinya Kameda, Akinori Maeda, Shun Maeda, Yutaro Inoue, Kazunari Takahashi, Akira Kageyama, Kent Doi, Tomoko Fujii

Get full text